XSHE
300962
Market cap517mUSD
Oct 09, Last price
13.00CNY
1D
-0.91%
1Q
2.12%
IPO
-59.93%
Name
Zhongjin Irradiation Incorporated Co
Chart & performance
P/E
28.95
P/S
9.43
EPS
0.45
Div yield, %
1.11%
Shrs. gr., 5y
1.30%
Rev. gr., 5y
3.33%
Revenues
364m
+1.54%
Net income
119m
+8.90%
CFO
217m
+12.10%
Dividend
Jul 27, 20260.09 CNY/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Established in 2003 and headquartered in Shenzhen, China, Zhongjin Irradiation Incorporated Company specializes in providing diverse irradiation solutions throughout the country. The company offers sterilization services utilizing irradiation for a wide range of items, including medical and healthcare goods, foodstuffs, pharmaceuticals, and various packaging materials. Additionally, they conduct irradiation modification tailored for polymer materials.
Key people
Mancao Zhang
Chief Accounting Officer · since 2018
Dongbo Zhang
General Manager, Director · since 2024
Yongsheng Bai
Deputy General Manager · since 2018
Jun Chen
(General Counsel) Chief Compliance Officer, Deputy General Manager, Secretary of the Board · since 2025
Qingsong Tang
Deputy General Manager · since 2011
Mei Yu
Deputy General Manager · since 2018
Guojiang Cheng
Director · since 2025
Zhonghua Fang
Chairman of the Board · since 2024
Chunhai Li
Director · since 2025
Weiming Liu
Director · since 2026
Qingsong Zhang
Director · since 2016
Xiyun Hu
Independent Director
Yunfei Jin
Independent Director · since 2023
Ying Liu
Independent Director · since 2018
Hongxiang Yu
Independent Director
Wei Zhang
Independent Director · since 2018
Yongfu Zhao
Independent Director · since 2017
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2023‑00 | 2022‑12 | 2022‑00 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||||
Revenues | ||||||||||||
Cost of revenue | ||||||||||||
Unusual Expense (Income) | ||||||||||||
NOPBT | ||||||||||||
NOPBT Margin | ||||||||||||
Operating Taxes | ||||||||||||
Tax Rate | ||||||||||||
NOPAT | ||||||||||||
Net income | ||||||||||||
Dividends | ||||||||||||
Dividend yield | ||||||||||||
Proceeds from repurchase of equity | ||||||||||||
BB yield | ||||||||||||
| Debt | ||||||||||||
Debt current | ||||||||||||
Long-term debt | ||||||||||||
Deferred revenue | ||||||||||||
Other long-term liabilities | ||||||||||||
Net debt | ||||||||||||
| Cash flow | ||||||||||||
Cash from operating activities | ||||||||||||
CAPEX | ||||||||||||
Cash from investing activities | ||||||||||||
Cash from financing activities | ||||||||||||
FCF | ||||||||||||
| Balance | ||||||||||||
Cash | ||||||||||||
Long term investments | ||||||||||||
Excess cash | ||||||||||||
Stockholders' equity | ||||||||||||
Invested Capital | ||||||||||||
ROIC | ||||||||||||
ROCE | ||||||||||||
| EV | ||||||||||||
Common stock shares outstanding | ||||||||||||
Price | ||||||||||||
Market cap | ||||||||||||
EV | ||||||||||||
EBITDA | ||||||||||||
EV/EBITDA | ||||||||||||
Interest | ||||||||||||
Interest/NOPBT | ||||||||||||